Hepatitis B virus gene mutations in liver diseases: A report from New Delhi

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Malik, Abdul ^a,b,c   Singhal, Deepak Kumar ^b   Albanyan, Abdulmajeed ^a   Husain, Syed Akhtar ^c   Kar, P ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b MAULANA AZAD MEDICAL COLLEGE   (India)

^c JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY;

ADULT; ARTICLE; CANCER RISK; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; FULMINANT HEPATIC FAILURE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROMOTER REGION; VIRUS CARRIER; VIRUS GENE; VIRUS HEPATITIS; VIRUS LOAD; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS TYPING;

ADULT; BASE SEQUENCE; DNA PRIMERS; FEMALE; HEPATITIS B VIRUS; HUMANS; INDIA; LIVER DISEASES; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 84862248170     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039028     Document Type: Article

References (47)

1. Kao JH, Chen PJ, Lai MY, Chen DS, (2002) Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbiol 40: 1207-1209.
2. Hannoun C, Horal P, Lindh M, (2000) Long-term mutation rates in the hepatitis B virus genome. J Gen Virol 81: 75-83.
3. Kidd-Ljunggren K, Miyakawa Y, Kidd AH, (2002) Genetic variability in hepatitis B viruses. J Gen Virol 83: 1267-1280.
4. Kidd-Ljunggren K, Myhre E, Blackberg J, (2004) Clinical and serological variation between patients infected with different Hepatitis B virus genotypes. J Clin Microbiol 42: 5837-5841.
5. Chen CH, Lee CM, Hung CH, Hu TH, Wang JH, et al. (2007) Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study. Liver Int 27: 806-815.
6. Lin CL, Liu CH, Chen W, Huang WL, Chen PJ, et al. (2007) Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol 22: 1098-1103.
7. Seeger C, Mason WS, (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64(1): 51-68.
8. Tsai WL, Lo GH, Hsu PI, Lai KH, Lin CK, et al. (2008) Role of genotype and precore/basal core promoter mutations of hepatitis B virus in patients with chronic hepatitis B with acute exacerbation. Scand J Gastroenterol 43(2): 196-201.
9. Jammeh S, Tavner F, Watson R, Thomas HC, Karayiannis P, (2008) Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. J Gen Virol 89(Pt 4): 901-909.
10. Tong MJ, Blatt LM, Kao JH, Cheng JT, Corey WG, (2007) Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers. Liver Int 27(10): 1356-1363.
11. Yuen MF, Tanaka Y, Shinkai N, Poon RT, But DY, et al. (2008) Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut 57(1): 98-102.
12. Fang ZL, Sabin CA, Dong BQ, Ge LY, Wei SC, et al. (2008) HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study. Am J Gastroenterol 103(9): 2254-2262.
13. Chen CH, Changchien CS, Lee CM, Hung CH, Hu TH, et al. (2008) Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study. J Infect Dis 198(11): 1634-1642.
14. Tanaka Y, Mukaide M, Orito E, Yuen MF, Ito K, et al. (2006) Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 45(5): 646-653.
15. Abbas Z, Muzaffar R, Siddiqui A, Naqvi SA, Rizvi SA, (2006) Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi. BMC Gastroenterol pp. 6-20.
16. Rezende RE, Fonseca BA, Ramalho LN, Zucoloto S, Pinho JR, et al. (2005) The precore mutation is associated with severity of liver damage in Brazilian patients with chronic hepatitis. B J Clin Virol 32(1): 53-59.
17. Xu Z, Ren X, Liu Y, Li X, Bai S, et al. (2011) Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure. J Gastroenterol 46(3): 391-400.
18. Du H, Li T, Zhang HY, He ZP, Dong QM, et al. (2007) Correlation of hepatitis B virus (HBV) genotypes and mutations in basal core promoter/precore with clinical features of chronic HBV infection. Liver Int 27(2): 240-246.
19. Chen CH, Lee CM, Lu SN, Changchien CS, Wang JC, et al. (2006) Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy. J Hepatol 44(1): 76-82.
20. Jain RC, Bhat SD, Sangle DS, (1992) Prevalence of hepatitis surface antigen among rural population of Loni area in Ahmednagar district of Western Maharashtra. J Assoc Physicians India 40: 390-391.
21. Mital VN, Gupta OP, Nigam DK, Saxena PC, Kumar S, (1980) Pattern of hepatitis B antigen-contact and carrier state in Northern India. J Indian Med Assoc 74: 105-107.
22. Thyagarajan SP, Jayaram S, Mohanavalli B, (1996) Prevalence of HBV in general population of India. In S. K. Sarin and A. K. Singhal (eds). Hepatitis B in India: Problems and Prevention. CBS, New Delhi pp. 5-16.
23. Aggarwal R, Ghoshal UC, Naik SR, (2003) Assessment of cost effectiveness of universal hepatitis B immunization in a low income country with intermediate endemicity using a Markov model. J Hepatol 38: 215-222.
24. Gandhe SS, Chadha MS, Walimbe AM, Arankalle VA, (2003) Hepatitis B virus: Prevalence of precore/core promoter mutants in different clinical categories of Indian patients. J Viral Hepat 10: 367-382.
25. Ikeda KY, Arase SS, Kobayashi M, Someya T, Hosaka T, et al. (2006) Long-term outcome of HBV carriers with negative HBe antigen and normal aminotransferase. Am J Med 119: 977-985.
26. Irshad M, Sharma Y, I Dhar, J Singh, YK Joshi, (2006) Transfusion-transmitted virus in association with hepatitis A-E viral infections in various forms of liver diseases in India. World J Gastroenterol 12(15): 2432-2436.
27. Trey C, Davidson CS, (1970) The management of fulminant hepatic failure. In: Popper, H Scaffner, F, editors. pp. 282-98 eds. Progress in liver failure. New york: Grune & Stratton.
28. Xiao L, Zhou B, Gao H, Ma S, Yang G, et al. (2011) Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure. J Med Virol. 83(9): 1544-1550.
29. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, et al. (2001) J. EASL Panel of Experts on HCC.
30. Tian Y, Xu Y, Zhang Z, Meng Z, Qin L, et al. (2007) The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J Clin Microbiol 45: 2971-2978.
31. Bartholomeusz A, Locarnini S, (2006) Hepatitis B virus mutations associated with antiviral therapy. J Med Virol 78 (1): 52-55.
32. Angus P, Vaughan R, Xiong S, Yang H, Delaney W, et al. (2003) Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 125: 292-297.
33. Olinger CM, Weber B, Otegbayo JA, Ammerlaan W, Van der Taelem-Brule N, et al. (2007) Hepatitis B virus genotype E surface antigen detection with different immunoassays and diagnostic impact of mutations in the preS/S gene. Med Microbiol Immunol 196: 247-252.
34. Tatti KM, Korba BE, Stang HL, Peek S, Gerin JL, et al. (2002) Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine. Antiviral Res 55: 141-150.
35. Frank T, Christina G, Tom L, Albert H, Michael P, et al. (2004) Basal Core Promoter and Precore Mutations in the Hepatitis B Virus Genome Enhance Replication Efficacy of Lamivudine-Resistant Mutants. J Virol 78(16): 8524-8535.
36. Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E, (1991) A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 324: 1705-1709.
37. Akahane Y, Yamanaka T, Suzuki H, Sugai Y, Tsuda F, et al. (1990) Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. Gastroenterology 99: 1113-1119.
38. Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, et al. (1990) Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 64: 1298-1303.
39. Akarka US, Greene S, Lok ASF, (1994) Detection of pre-core hepatitis B virus mutants in asymptomatic HBsAg-positive family members. Hepatology 19: 1366-1370.
40. Chan HLY, Hussain M, Lok ASF, (1999) Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology 29: 976-984.
41. Chan HLY, Leung NWY, Hussain M, Wong ML, Lok ASF, (2000) Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology 31: 763-768.
42. Brunetto MR, Oliveri F, Coco B, Leandro G, Colombatto P, et al. (2002) Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. J Hepatol 36: 263-270.
43. Kao JH, Chen PJ, Lai MY, Chen DS, (2003) Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124: 327-334.
44. Kim BK, Revill PA, Ahn SH, (2011) HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B. Antivir Ther 16(8): 1169-1186.
45. Wang Z, Tanaka Y, Huang Y, Kurbanov F, Chen J, et al. (2007) Clinical and virological characteristics of hepatitis B virus subgenotypes Ba, C1, and C2 in China. J Clin Microbiol 45: 1491-1496.
46. Chen CH, Lee CM, Lu SN, Changchien CS, Eng HL, et al. (2005) Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan. J Clin Microbiol 43: 6000-6006.
47. Takahashi K, Ohta Y, Kanai K, Akahane Y, Iwasa Y, et al. (1999) Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease. Arch Virol 144: 1299-1308.